Analyst consensus rating
Seaport Therapeutics Analyst Rating: Strong Buy
SPTX is rated Strong Buy by 5 analysts with a $38.00 target. As of 2026-08-26.
Direct answer
Seaport Therapeutics's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $38.00.
Forecast evidence checked August 26, 2026.
Get free Seaport Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $24.83
- Average price target
- $38.00
- High price target
- $50.00
- Low price target
- $30.00
- Low target gap
- +20.8%
- Target upside
- +53%
- High target gap
- +101.4%
- Target range width
- 80.5%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Seaport Therapeutics?
Seaport Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $38.00.
How far are Seaport Therapeutics's low and high targets from the recorded price?
The low target implies +20.8%, while the high target implies +101.4%.
How many analysts are included in Seaport Therapeutics's consensus?
The verified consensus includes 5 analysts.
How is Seaport Therapeutics's target upside or downside calculated?
The average target of $38.00 is divided by the recorded price of $24.83, then one is subtracted to produce +53%. This does not guarantee a future return.
When was Seaport Therapeutics's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.